Pharmaceutics_R&D
3.9K views | +0 today
Follow
Pharmaceutics_R&D
Pharmaceutical companies R&D specifically in neuroscience, CNS disease, pain and electrophysiology
Your new post is loading...
Your new post is loading...
Scooped by Julien Hering, PhD
Scoop.it!

Crowdfunding Is Coming to Biotech, so Get Ready for a Wild Ride | Xconomy

Crowdfunding Is Coming to Biotech, so Get Ready for a Wild Ride | Xconomy | Pharmaceutics_R&D | Scoop.it

Most biotech pros will shrug, or chuckle, if you ask whether crowdfunding will transform life sciences financing in the U.S.


This, after all, is an industry where you often need to raise at least $50 million or $100 million to even have a chance at developing a new drug or medical device. Scraping together a few thousand bucks from individuals on the Internet isn’t going to go very far. One venture capitalist recently told me, “there are a lot of things I worry about, but crowdfunding isn’t one of them.” (...) - By Luke Timmerman, Xconomy, 1/28/2013

more...
No comment yet.
Scooped by Julien Hering, PhD
Scoop.it!

ANTABIO and WiSEED announce the completion of the first successful round of crowdfunding applied to biotech start-up financing - FierceBiotech

ANTABIO and WiSEED announce the completion of the first successful round of crowdfunding applied to biotech start-up financing.

Labège, France, October 1st, 2012. ANTABIO, the biopharmaceutical antibacterial drug discovery company, and WiSEED, the French crowdfunding platform dedicated to innovative & technologic startups, announce the successful completion of their seed round of financing with a profitable exit of the initial small investors, a world premiere in the field of crowdfunding applied to biotech start-up financing.

Read more: ANTABIO and WiSEED announce the completion of the first successful round of crowdfunding applied to biotech start-up financing (...) - FierceBiotech 

more...
No comment yet.